| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |